CoChat

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016

Open access

Abstract

BACKGROUND: Stimulants are considered the first-line treatment for Attention Deficit Hyperactivity Disorder (ADHD) in the US and they are used in other indications. Stimulants are also diverted for non-medical purposes. Ethnic and regional differences in ADHD diagnosis and in stimulant use have been identified in earlier research. The objectives of this report were to examine the pharmacoepidemiological pattern of these controlled substances over the past decade and to conduct a regional analysis. METHODS: Data (drug weights) reported to the US Drug Enforcement Administration's Automation of Reports and Consolidated Orders System for four stimulants (amphetamine, methylphenidate, lisdexamfetamine, and methamphetamine) were obtained from 2006 to 2016 for Unites States/Territories. Correlations between state level use (mg/person) and Hispanic population were completed. RESULTS: Amphetamine use increased 2.5 fold from 2006 to 2016 (7.9 to 20.0 tons). Methylphenidate use, at 16.5 tons in 2006, peaked in 2012 (19.4 tons) and subsequently showed a modest decline (18.6 tons in 2016). The consumption per municipality significantly increased 7.6% for amphetamine and 5.5% for lisdexamfetamine but decreased 2.7% for methylphenidate (all p < .0005) from 2015 to 2016. Pronounced regional differences were also observed. Lisdexamfetamine use in 2016 was over thirty-fold higher in the Southern US (43.8 mg/person) versus the Territories (1.4 mg/person). Amphetamine use was about one-third lower in the West (48.1 mg/person) relative to the Northeastern (75.4 mg/person, p < .05) or the Midwestern (69.9 mg/person, p ≤ .005) states. States with larger Hispanic populations had significantly lower methylphenidate (r(49) = -0.63), lisdexamfetamine (B, r(49) = -0.49), and amphetamine (r(49) = -0.43) use. CONCLUSIONS: Total stimulant usage doubled in the last decade. There were dynamic changes but also regional disparities in the use of stimulant medications. Future research is needed to better understand the reasons for the sizable regional and ethnic variations in use of these controlled substances.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0206100

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Total weight of amphetamine, methylphenidate, lisdexamfetamine, and methamphetamine in the US and territories from 2006 to 2016. (A). Regional analysis of these drugs in 2016. Lixdex: lisdexamfetamine. tp ≤ .001 versus the US Territories; wp < .05 versus the western states (B). Scatterplot depicting moderate association (R2 = 0.40) between percent of the state comprised of Hispanic citizens according to the 2015 US Census and population corrected use of methylphenidate (C).
Fig 1 Total weight of amphetamine, methylphenidate, lisdexamfetamine, and methamphetamine in the US and territories from 2006 to 2016. (A). Regional analysis of these drugs in 2016. Lixdex: lisdexamfetamine. tp ≤ .001 versus the US Territories; wp < .05 versus the western states (B). Scatterplot depicting moderate association (R2 = 0.40) between percent of the state comprised of Hispanic citizens according to the 2015 US Census and population corrected use of methylphenidate (C).CC BY · PubMed Central
Fig 2 Heat map of per capita of amphetamine (A, top), methylphenidate (B, middle), or lisdexamfetamine (C, bottom) as reported to the Drug Enforcement Administration in 2016. Ratio relative to the lowest state (amphetamine = 25.52 mg/capita, methylphenidate = 19.70 mg/capita, lisdexamfetamine = 3.63 mg/capita).
Fig 2 Heat map of per capita of amphetamine (A, top), methylphenidate (B, middle), or lisdexamfetamine (C, bottom) as reported to the Drug Enforcement Administration in 2016. Ratio relative to the lowest state (amphetamine = 25.52 mg/capita, methylphenidate = 19.70 mg/capita, lisdexamfetamine = 3.63 mg/capita).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 85 references

Research works printed but not linked: 1

  1. G Jachimowicz, 2004, Comparison of ease of falsification of Attention Deficit Hyperactivity Disorder diagnosis using standard behavioral rating scales, Cognitive Science Online, 2, 6

Cited by

See all 186

Metadata

Authors
Piper, B. J., Ogden, C. L., Simoyan, O. M., Chung, D. Y., Caggiano, J. F., Nichols, S. D., & McCall, K. L.
Affiliations
  • Geisinger College of Health Sciences (US)
  • Tufts University (US)
  • University of New England (US)
Corresponding author
Piper, Brian J.
Venue
PLOS ONE
Published
2018-11-28
Volume
13
Issue
11
Pages
e0206100
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2903069810
Cited by
170
References
85
Citations by year
2026: 8 · 2025: 23 · 2024: 15 · 2023: 27 · 2022: 42 · 2021: 24 · 2020: 23 · 2019: 6
FWCI
10.35
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Institute of Environmental Health Sciences (T32 ES007060-31A1)
  • Husson University School of Pharmacy (2013-01)
  • Fahs-Beck Fund for Research and Experimentation (2017-01)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
stimulant medication, amphetamine, methylphenidate, lisdexamfetamine, methamphetamine, ADHD medication, drug diversion, regional disparities, Hispanic population, pharmacoepidemiology, controlled substances, drug use trends, Southern United States, northeastern United States, ethnic disparities
MeSH terms
Central Nervous System Stimulants, Geography, Humans, United States, United States Food and Drug Administration, Prescriptions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016. https://app.cochat.ai/papers/10.1371/journal.pone.0206100
The paper
Piper, B. J., Ogden, C. L., Simoyan, O. M., Chung, D. Y., Caggiano, J. F., Nichols, S. D., & McCall, K. L. (2018). Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016. PLOS ONE. https://doi.org/10.1371/journal.pone.0206100

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.